Latest App Notes & Case Studies

Microbial whole-genome sequencing (WGS) can support taxanomic classification, functional characterization and identify anti-microbial resistance in diverse sample types. It can provide greater resolution and more quantitative insights compared to shotgun and 16S methods.

The 16S ribosomal RNA (16S rRNA) gene is present in most bacterial species. As it contains both highly conserved and variable regions, it can be used to identify and classify different taxonomic levels.

This application note demonstrates how Single Cell Immune Profiling and Barcode Enabled Antigen Mapping (BEAM) can be used to profile thousands of hPBMCs from a single donor.

Metabolism has emerged as a key driver of T-cell antitumor function. This means that modulating metabolic programs of T cells can be used as a strategy to improve the antitumor efficacy of adoptive T-cell therapies.

The multi-attribute method (MAM) is a powerful LC-MS method that overcomes this challenge by simultaneously monitoring and quantifying multiple PQAs in a single injection.

Find out how scientists determined which of five extraction methods was optimal for use in a long-read sequencing workflow by comparing the sample quality, sample size and sequencing results.

Download this tech note to learn how mass spectrometry has gained substantial popularity for therapeutic mAb monitoring in clinical laboratories due to its great versatility to detect both tryptic peptides and intact light and heavy chains quantitatively.

Identifying a respiratory viral infection can be challenging with different families of viruses being indistinguishable during the acute phase of illness, despite the outcome and long-term prognosis of the infection being different. The ability to diagnose a respiratory virus at the initial stage of infection can result in more effective treatment for the patient.

Download this app note to discover a method that facilitates optimal and reproducible conditions and thus reliable results, provides optimal activity-based cytokine dosing plus saves reagent.

One approach to develop drugs for infectious diseases involves a comprehensive understanding of human-pathogen protein interactions, as targeting host proteins helps reduce the possibility of drug resistance by creating a more significant evolutionary barrier for the virus.